Myocardial metabolism in toxin-induced heart failure and therapeutic implications

Clinical Toxicology

Volumn 50, Issue 3, 2012, Pages 166-171

  Hantson, Philippe ^a   Beauloye, Christophe ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Drug poisoning; Insulin; Myocardial metabolism; Stunned myocardium; Takotsubo cardiomyopathy

Indexed keywords

ADRENALIN; ANAGRELIDE; ATROPINE; BACLOFEN; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOTOXIN; CEFOTIAM; COCAINE; DIPYRIDAMOLE; DOBUTAMINE; DULOXETINE; EPHEDRINE; ERGOMETRINE; FLUOROURACIL; HYPERTENSIVE AGENT; INOTROPIC AGENT; INSULIN; LEVOTHYROXINE; LOCAL ANESTHETIC AGENT; LUMIRACOXIB; METOPROLOL; NORTRIPTYLINE; OPIATE; OXYMETAZOLINE; PAZOPANIB; POTASSIUM CHLORIDE; UNINDEXED DRUG; VENLAFAXINE;

ARTICLE; CARBOHYDRATE METABOLISM; DRUG INTOXICATION; DRUG MEGADOSE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART FAILURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INOTROPISM; INSULIN RESISTANCE; NONHUMAN; STUNNED HEART MUSCLE; TAKOTSUBO CARDIOMYOPATHY;

ANTIDOTES; CARDIOTOXINS; HEART; HEART FAILURE; HUMANS; INSULIN; MYOCARDIAL STUNNING; MYOCARDIUM; POISONING; TAKOTSUBO CARDIOMYOPATHY;

EID: 84857715354     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2012.658472     Document Type: Article

References (33)

1. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005;85: 1093-1129. (Pubitemid 40894649)
2. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation-a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta 2011;1813:1333-1350.
3. Chen CH, Liu YF, Lee SD, Huang CY, Lee WC, Tsai YL, et al. Altitude hypoxia increases glucose uptake in human heart. High Alt Med Biol 2009;10:83-86.
4. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998;339:173-181.
5. Dorbala S, Di Carli MF. Metabolic Imaging of Myocardial Stunning. Heart Metabolism 2003;19:18-22.
6. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008;155:408-417.
7. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352: 539-548. (Pubitemid 40204667)
8. Amariles P. A comprehensive literature search: drugs as possible triggers of Takotsubo cardiomyopathy. Curr Clin Pharmacol 2011;6:1-11.
9. De Roock S, Beauloye C, De Bauwer I, Vancraynest D, Gurne O, Gerber B, et al. Tako-tsubo syndrome following nortriptyline overdose. Clin Toxicol 2008;46:475-478. (Pubitemid 351878653)
10. Biswas AK, Feldman BL, Davis DH, Zintz EA. Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal. Clin Toxicol 2005;43:207-209. (Pubitemid 40675656)
11. Rivera JM, Locketz AJ, Fritz KD, Horlocker TT, Lewallen DG, Pras-ad A, et al. "Broken heart syndrome" after separation (from Oxy-Contin). Mayo Clin Proc 2006;81:825-828. (Pubitemid 43839498)
12. Pizon AF, Lovecchio F. Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: a case report. Am J Emerg Med 2010;28:387.e5-e6.
13. Lemesle F, Lemesle F, Nicola W, Pierre Jonville-Béra A. First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction. J Med Toxicol 2007;3: 187-189.
14. Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and b ê ta-receptor agonists. J Am Coll Cardiol 2009;53: 1320-325.
15. De Boeck BW, Verburg FA, Hobbelink MG, Velthuis B, Melman PG, Cramer MJ. Reversible 18-FDG-uptake defects on myocardial PET: Is this myocardial resurrection? Int J Cardiol. 2008;127:e175-e178. (Pubitemid 351885115)
16. Rendl G, Rettenbacher L, Keinrath P, Altenberger J, Schuler J, Heigert M, et al. Different pattern of regional metabolic abnormalities in Takotsubo cardiomyopathy as evidenced by F-18 FDG PET-CT. Wien Klin Wochenschr 2010;122:184-185.
17. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, et al. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol 2003;41:743-748. (Pubitemid 36308379)
18. Cimarelli S, Sauer F, Morel O, Ohlmann P, Constantinesco A, Im-periale A. Transient left ventricular dysfunction syndrome: patho-physiological bases through nuclear medicine imaging. Int J Cardiol 2010;144:212-218.
19. Panchal AR, Stanley WC, Kerner J, Sabbah HN. B ê ta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure. J Card Fail 1998;4:121-126. (Pubitemid 28381150)
20. Reikerås O, Gunnes P, S ø rlie D, Ekroth R, Mj ø s OD. Metabolic effects of low and high doses of insulin during B ê ta-receptor blockade in dogs. Clin Physiol 1985;5:469-478.
21. Levine M, Boyer EW, Pozner CN, Geib AJ, Thomsen T, Mick N, et al. Assessment of hyperglycemia after calcium channel block-er overdoses involving diltiazem or verapamil. Crit Care Med 2007;35:2071-2075. (Pubitemid 47326443)
22. Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabeto-genic effects of acute verapamil poisoning. Toxicol Appl Pharmacol 1997;145:357-362. (Pubitemid 27346525)
23. Kline JA, Leonova E, Williams TC, Schroeder JD, Watts JA. Myo-cardial metabolism during graded intraportal verapamil infusion in awake dogs. J Cardiovasc Pharmacol 1996;27:719-726. (Pubitemid 26134249)
24. Bechtel LK, Haverstick DM, Holstege CP. Verapamil toxicity dys-regulates the phosphatidylinositol 3-kinase pathway. Acad Emerg Med 2008;15:368-374.
25. Louters LL, Stehouwer N, Rekman J, Tidball A, Cok A, Holstege CP. Verapamil inhibits the glucose transport activity of GLUT1. J Med Toxicol 2010;6:100-105.
26. Kline JA, Raymond RM, Leonova ED, Williams TC, Watts JA. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovasc Res 1997;34: 289-298. (Pubitemid 27241573)
27. Kline JA, Leonova E, Raymond RM. Benef cial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995;23:1251-1263.
28. Weinberg GL, Palmer JW, VadeBoncouer TR, Zuechner MB, Edel-man G, Hoppel CL. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology 2000;92:523-528. (Pubitemid 30078352)
29. Edelman LB, Ripper R, Kelly K, Di Gregorio G, Weinberg GL. Metabolic context affects hemodynamic response to bupivacaine in the isolated rat heart. Chem Biol Interact 2008;172:48-53.
30. Klein LJ, van Campen CM, Sieswerda GT, Kamp O, Visser FC. Effects of high-dose insulin infusion on left ventricular function in normal subjects. Neth Heart J 2010;18:183-189.
31. Hsu C-H, Wei J, Chen Y-C, Yang S-P, Tsai C-S, Lin C-I. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium. J Heart Lung Transplant 2006;25:1126-1134. (Pubitemid 44311528)
32. Weinberg GL, Ripper R, Bern S, Lin B, Edelman L, Digregorio G, et al. Pioglitazone attenuates acute cocaine toxicity in rat isolated heart: potential protection by metabolic modulation. Anesthesiology 2011;114:1389-1395.
33. Foretz M, Taleux N, Guigas B, Horman S, Beauloye C, Andreelli F, et al. Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases. Med Sci 2006;22:381-388.